# Oxytocin for Oxidative Stress and Inflammation

> **NCT04732247** · PHASE2 · COMPLETED · sponsor: **Florida Institute for Human and Machine Cognition** · enrollment: 40 (actual)

## Conditions studied

- Oxidative Stress
- Inflammation

## Interventions

- **DRUG:** Oxytocin nasal spray
- **DRUG:** Placebo nasal spray

## Key facts

- **NCT ID:** NCT04732247
- **Lead sponsor:** Florida Institute for Human and Machine Cognition
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-02-01
- **Primary completion:** 2023-09-15
- **Final completion:** 2023-09-15
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2024-02-22

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04732247

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04732247, "Oxytocin for Oxidative Stress and Inflammation". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04732247. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*